Results of phase III study of biosimilar infliximab in patients with rheumatoid arthritis June 22, 2015
Anika Therapeutics forms strategic collaboration with the Institute for Applied Life Sciences June 22, 2015
Improvement in growth velocity observed in phase II study of BMN-111 for achondroplasia June 18, 2015
Corbus Pharmaceuticals' Resunab receives FDA orphan drug designation for systemic sclerosis June 16, 2015
RSS